These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 16147598

  • 1. Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors.
    Lakhani K, Prelevic GM, Seifalian AM, Atiomo WU, Hardiman P.
    J Obstet Gynaecol; 2004 Sep; 24(6):613-21. PubMed ID: 16147598
    [Abstract] [Full Text] [Related]

  • 2. Polycystic ovarian syndrome: the next cardiovascular dilemma in women?
    Srikanthan P, Korenman S, Davis S.
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):611-31, x. PubMed ID: 16959589
    [Abstract] [Full Text] [Related]

  • 3. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F, Vuolo L, Palomba S, Lombardi G, Colao A.
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cardiovascular disease risk factors in polycystic ovary syndrome.
    Dokras A.
    Semin Reprod Med; 2008 Jan; 26(1):39-44. PubMed ID: 18181081
    [Abstract] [Full Text] [Related]

  • 6. Cardiometabolic features of polycystic ovary syndrome.
    Hoffman LK, Ehrmann DA.
    Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):215-22. PubMed ID: 18250636
    [Abstract] [Full Text] [Related]

  • 7. [Long-term risks of polycystic ovaries syndrome].
    Lefebvre P, Raingeard I, Renard E, Bringer J.
    Gynecol Obstet Fertil; 2004 Mar; 32(3):193-8. PubMed ID: 15123116
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular health in women with polycystic ovary syndrome.
    Sukalich S, Guzick D.
    Semin Reprod Med; 2003 Aug; 21(3):309-15. PubMed ID: 14593554
    [Abstract] [Full Text] [Related]

  • 9. Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome.
    Cattrall FR, Healy DL.
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):803-12. PubMed ID: 15380148
    [Abstract] [Full Text] [Related]

  • 10. Metabolic and vascular abnormalities in subjects at risk for type 2 diabetes: the early start of a dangerous situation.
    Caballero AE.
    Arch Med Res; 2005 Oct; 36(3):241-9. PubMed ID: 15925014
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E, Jarosz-Chobot P, Deja G.
    Przegl Lek; 2006 Oct; 63(4):234-8. PubMed ID: 17080748
    [Abstract] [Full Text] [Related]

  • 13. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.
    Moran L, Teede H.
    Hum Reprod Update; 2009 Oct; 15(4):477-88. PubMed ID: 19279045
    [Abstract] [Full Text] [Related]

  • 14. The metabolic syndrome in polycystic ovary syndrome.
    Essah PA, Wickham EP, Nestler JE.
    Clin Obstet Gynecol; 2007 Mar; 50(1):205-25. PubMed ID: 17304037
    [Abstract] [Full Text] [Related]

  • 15. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
    Bethea SW, Nestler JE.
    Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
    [Abstract] [Full Text] [Related]

  • 16. Obesity and the polycystic ovary syndrome.
    Magnotti M, Futterweit W.
    Med Clin North Am; 2007 Nov; 91(6):1151-68, ix-x. PubMed ID: 17964914
    [Abstract] [Full Text] [Related]

  • 17. Type 2 diabetes and polycystic ovary syndrome.
    Legro RS.
    Fertil Steril; 2006 Jul; 86 Suppl 1():S16-7. PubMed ID: 16798276
    [Abstract] [Full Text] [Related]

  • 18. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C.
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
    [Abstract] [Full Text] [Related]

  • 19. Cardiovascular risk in women with polycystic ovary syndrome.
    Cho LW, Atkin SL.
    Minerva Endocrinol; 2007 Dec; 32(4):263-73. PubMed ID: 18091663
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular risk factors are reduced with a low dose of acarbose in obese patients with polycystic ovary syndrome.
    Araujo Penna I, Canella PR, Vieira CS, Silva de Sá MF, dos Reis RM, Ferriani RA.
    Fertil Steril; 2007 Aug; 88(2):519-22. PubMed ID: 17418836
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.